Seres Appoints Chief Commercial Officer
This article was originally published in Scrip
Seres Therapeutics Inc., a microbiome therapeutics company, has appointed Wael Hashad chief commercial officer and executive vice president. Hashad has over 25 years' experience in launching therapies for companies including Amgen, Boehringer Ingelheim and Lilly. Most recently he was vice president and regional general manager at Amgen.
Register for our free email digests: